PremiumRatingsPositive Outlook for Boston Scientific: Farapulse PFA System Outperforms Competitor in Atrial Arrhythmia Trial Boston Scientific: Strong Market Position and Growth Potential Justify Buy Rating Boston Scientific put volume heavy and directionally bearish PremiumThe FlyBoston Scientific put volume heavy and directionally bearish Boston Scientific price target raised to $130 from $105 at Argus Optimistic 2025 Outlook and Strong Innovation Drive Buy Rating for Boston Scientific PremiumThe FlyBoston Scientific price target raised to $115 from $100 at Stifel Boston Scientific price target raised to $120 from $112 at Baird Boston Scientific price target raised to $117 from $101 at Canaccord 
